KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Minority Interest (2016 - 2025)

Historic Minority Interest for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$534.2 million.

  • Gsk's Minority Interest rose 2591.67% to -$534.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$534.2 million, marking a year-over-year increase of 2591.67%. This contributed to the annual value of -$747.8 million for FY2024, which is 891.37% down from last year.
  • Per Gsk's latest filing, its Minority Interest stood at -$534.2 million for Q3 2025, which was up 2591.67% from -$583.0 million recorded in Q2 2025.
  • In the past 5 years, Gsk's Minority Interest registered a high of $8.7 billion during Q3 2021, and its lowest value of -$775.1 million during Q1 2024.
  • For the 5-year period, Gsk's Minority Interest averaged around $2.2 billion, with its median value being -$588.8 million (2022).
  • Per our database at Business Quant, Gsk's Minority Interest tumbled by 10843.67% in 2023 and then skyrocketed by 2591.67% in 2025.
  • Quarter analysis of 5 years shows Gsk's Minority Interest stood at $8.5 billion in 2021, then plummeted by 106.95% to -$588.8 million in 2022, then decreased by 16.36% to -$685.1 million in 2023, then decreased by 9.59% to -$750.8 million in 2024, then increased by 28.85% to -$534.2 million in 2025.
  • Its last three reported values are -$534.2 million in Q3 2025, -$583.0 million for Q2 2025, and -$633.5 million during Q1 2025.